Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+137.0%
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+137.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
13.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$12.57M+168.6%
2023$4.68M+21.3%
2022$3.86M+308.9%
2021$943933.00+381.9%
2020$195860.00-